Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Preoperative Preradiotherapy TTFields

NCT: NCT06136611 · RECRUITING

NCT IDNCT06136611
StatusRECRUITING
Start Date2024-12-19
Completion2026-12-30

Brief Summary

PreOperative PreRAdIotherapy Tumour Treating Fields (PORTRAIT) is a Phase I study that will test the safety and feasibility of Optune administered preoperatively and preradiotherapy in patients with a new radiological diagnosis of glioblastoma (GBM). Participants will be required to undergo additional MRI sequencing scans and provide blood, tear fluid and tissue samples over a maximum of 6 months. After the study patients will follow their standard treatment pathway.

Frequently Asked Questions

What is Preoperative Preradiotherapy TTFields?

Preoperative Preradiotherapy TTFields is a clinical trial registered under NCT06136611. Current status: RECRUITING.

What is the status of NCT06136611?

The current status of NCT06136611 (Preoperative Preradiotherapy TTFields) is: RECRUITING.

When did Preoperative Preradiotherapy TTFields start?

Preoperative Preradiotherapy TTFields started on 2024-12-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.